ANRO Earnings

Quarterly EPS
$-0.62
Q3 2024
$-0.56
Q4 2024
$-0.56
Q1 2025
$-0.65
Q2 2025
$-0.52
Q3 2025
$-0.47
Q4 2025
$-0.80
Q1 2026
$-0.65
Q2 2026
Latest RevenueN/A
Latest Net Income-27638000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.650-27638000+0.0%
Q1 2026-$0.800-26237000-42.9%
Q4 2025-$0.470-16182000+16.1%
Q3 2025-$0.520-14181000+16.1%
Q2 2025-$0.650-17706000-8.3%
Q1 2025-$0.560-15169000+26.3%
Q4 2024-$0.560-15201000
Q3 2024-$0.620-16783000
Q2 2024-$0.600-16030000
Q1 2024-$0.760-13417000
Alto Neuroscience (ANRO) — Earnings